CD38 and B-cell chronic lymphocytic leukemia: CLL prognosis is dependent on clinical Rai (United States) or Binet (Europe) staging and biological markers, including IGHV status, cytogenetic abnormalities, NOTCH1 or SF3B1 mutations, and the expression of proteins such as CD38 or ZAP70 [3–5].